These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 11697627)
81. Double-hit lymphomas constitute a highly aggressive subgroup in diffuse large B-cell lymphomas in the era of rituximab. Kobayashi T; Tsutsumi Y; Sakamoto N; Nagoshi H; Yamamoto-Sugitani M; Shimura Y; Mizutani S; Matsumoto Y; Nishida K; Horiike S; Asano N; Nakamura S; Kuroda J; Taniwaki M Jpn J Clin Oncol; 2012 Nov; 42(11):1035-42. PubMed ID: 22984125 [TBL] [Abstract][Full Text] [Related]
82. Prognostic value of chromosomal translocations in small-bowel diffuse large B-cell lymphoma. Ikegami K; Nakamura S; Esaki M; Yanai S; Hirahashi M; Oda Y; Takeshita M; Matsumoto T; Kitazono T Histopathology; 2016 Jan; 68(2):199-209. PubMed ID: 25953462 [TBL] [Abstract][Full Text] [Related]
83. IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Valera A; Balagué O; Colomo L; Martínez A; Delabie J; Taddesse-Heath L; Jaffe ES; Campo E Am J Surg Pathol; 2010 Nov; 34(11):1686-94. PubMed ID: 20962620 [TBL] [Abstract][Full Text] [Related]
84. Histogenetic correlations between subcategories of small noncleaved cell lymphomas. Yano T; van Krieken JH; Magrath IT; Longo DL; Jaffe ES; Raffeld M Blood; 1992 Mar; 79(5):1282-90. PubMed ID: 1311213 [TBL] [Abstract][Full Text] [Related]
85. BCL6 gene rearrangements also occur in marginal zone B-cell lymphoma. Dierlamm J; Pittaluga S; Stul M; Wlodarska I; Michaux L; Thomas J; Verhoef G; Verhest A; Depardieu C; Cassiman JJ; Hagemeijer A; De Wolf-Peeters C; Van den Berghe H Br J Haematol; 1997 Sep; 98(3):719-25. PubMed ID: 9332330 [TBL] [Abstract][Full Text] [Related]
86. Rearrangements of immunoglobulin gene and oncogenes in ocular adnexal pseudolymphoma. Chen PM; Liu JH; Lin SH; Hsu WM; Kao SC Curr Eye Res; 1991 Jun; 10(6):547-55. PubMed ID: 1832632 [TBL] [Abstract][Full Text] [Related]
87. Identification of genetic lesions associated with diffuse large-cell lymphoma. Dalla-Favera R; Ye BH; Lo Coco F; Gaidano G; Lista F; Knowles DM; Louie DC; Offit K; Chaganti RS Ann Oncol; 1994; 5 Suppl 1():55-60. PubMed ID: 8172819 [TBL] [Abstract][Full Text] [Related]
88. Clinical significance of bcl-2 (MBR)/JH rearrangement in the peripheral blood of patients with diffuse large B-cell lymphomas. Zucca E; Bertoni F; Bosshard G; Roggero E; Ceresa E; Sanna P; Pedrinis E; Cavalli F Ann Oncol; 1996 Dec; 7(10):1023-7. PubMed ID: 9037360 [TBL] [Abstract][Full Text] [Related]
90. A subtype of aggressive B-cell lymphoma with an unusual presentation of effusion without masses. Kamihira S; Jiann C; Uemura A; Tsuruda K; Hasegawa H; Sugahara K; Yamada Y Leuk Lymphoma; 2006 Sep; 47(9):1991-3. PubMed ID: 17065024 [No Abstract] [Full Text] [Related]
91. Molecular genetics of gastrointestinal non-Hodgkin's lymphomas: unusual prevalence and pattern of c-myc rearrangements in aggressive lymphomas. van Krieken JH; Raffeld M; Raghoebier S; Jaffe ES; van Ommen GJ; Kluin PM Blood; 1990 Aug; 76(4):797-800. PubMed ID: 2200538 [TBL] [Abstract][Full Text] [Related]
92. Evidence of c-myc gene abnormalities in mediastinal large B-cell lymphoma of young adult age. Scarpa A; Borgato L; Chilosi M; Capelli P; Menestrina F; Bonetti F; Zamboni G; Pizzolo G; Hirohashi S; Fiore-Donati L Blood; 1991 Aug; 78(3):780-8. PubMed ID: 1713514 [TBL] [Abstract][Full Text] [Related]
93. The advantage of rearranging bcl-6. Mooi WJ N Engl J Med; 1994 Nov; 331(21):1459-60. PubMed ID: 7818707 [No Abstract] [Full Text] [Related]
94. Alterations on the 5' noncoding region of the BCL-6 gene are not correlated with BCL-6 protein expression in T cell non-Hodgkin lymphomas. Kerl K; Vonlanthen R; Nagy M; Bolzonello NJ; Gindre P; Hurwitz N; Gudat F; Nador RG; Borisch B Lab Invest; 2001 Dec; 81(12):1693-702. PubMed ID: 11742039 [TBL] [Abstract][Full Text] [Related]
95. bcl-2 gene rearrangement analysis in Japanese B cell lymphoma; novel bcl-2 recombination with immunoglobulin kappa chain gene. Osada H; Seto M; Ueda R; Emi N; Takagi N; Obata Y; Suchi T; Takahashi T Jpn J Cancer Res; 1989 Aug; 80(8):711-5. PubMed ID: 2511176 [TBL] [Abstract][Full Text] [Related]
96. The molecular biology of B-cell lymphoma: clinicopathologic implications. Kluin PM; van Krieken JH Ann Hematol; 1991 Apr; 62(4):95-102. PubMed ID: 2031977 [TBL] [Abstract][Full Text] [Related]
97. MYC, BCL2, BCL6 in DLBCL: impact for clinics in the future? Thieblemont C; Brière J Blood; 2013 Mar; 121(12):2165-6. PubMed ID: 23520325 [No Abstract] [Full Text] [Related]
98. Mediastinal large B-cell lymphoma: new evidence in support of its distinctive identity. Chan JK Adv Anat Pathol; 2000 Jul; 7(4):201-9. PubMed ID: 10907805 [No Abstract] [Full Text] [Related]
99. Aggressive CD5-positive diffuse large B cell lymphoma showing c-myc rearrangements developed in a patient with autoimmune hemolytic anemia. Sonoki T; Matsuzaki H; Asou N; Hata H; Matsuno F; Yoshida M; Nagasaki A; Kuribayashi N; Kudo H; Takatsuki K Int J Hematol; 1996 Jan; 63(1):71-6. PubMed ID: 8713579 [TBL] [Abstract][Full Text] [Related]
100. Case of B-cell lymphoma with rearrangement of the BCL1, BCL2, BCL6, and c-MYC genes. Kawakami K; Miyanishi S; Sonoki T; Nakamura S; Nomura K; Taniwaki M; Murata T; Kadowaki S; Kadowaki N; Miura I Int J Hematol; 2004 Jun; 79(5):474-9. PubMed ID: 15239399 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]